Jian Song

Dr. Jian Song


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2021 in Macromolecular Bioscience
Verified
Journal Article
Open access
PDF file
YCYuru Chen
Yuru Chen
JSJian Song
Jian Song
SWSong Wang
Song Wang
Weiqiang LiuWeiqiang Liu
Weiqiang Liu
Front Cover: Similar to the ancient Chinses mythology Goddess Nüwa Mending the Sky, PVA-based hydrogels can be also used for cartilage repair applications. The preparation and modification of PVA hydrogels are summarized, and the design disciplines and future perspectives in this field are discussed. This is reported by Yuru Chen, Jian Song, Song Wang, Weiqiang Liu in article number 2100147.

24 February 2021 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
ACAnhai Chen
Anhai Chen
JSJian Song
Jian Song
FAFrederic R. E. Acke
Frederic R. E. Acke
LMLingyun Mei
Lingyun Mei
Xinzhang CaiXinzhang Cai
Xinzhang Cai
CHChufeng He
Chufeng He

3 July 2023 in Environmental Science and Pollution Research
Verified
Journal Article
Open access
PDF file
YWYudong Wu
Yudong Wu
YMYajie Meng
Yajie Meng
WYWeizhuo Yi
Weizhuo Yi
RPRubing Pan
Rubing Pan
YLYunfeng Liang
Yunfeng Liang
HSHong Su
Hong Su
Tungsten (W) is an emerging contaminant that can damage multiple systems in humans. However, studies of its effects on cardiovascular disease (CVD) are limited. The monocyte count to high-density lipoprotein cholesterol ratio (MHR) is a composite inflammatory index of great concern in recent years, derived from lipid and cell inflammation parameters, that is used to indicate the risk of CVD. This study aimed to investigate the association between urinary W and CVD in the general population and compare the mediating effects of lipids, cell inflammatory parameters, and MHR to find a better target for intervention. We analyzed data from 9137 (≥ 20 years) participants in the National Health and Nutrition Examination Survey (NHANES), from 2005 to 2018. Restricted cubic splines (RCS) and survey-weighted generalized linear models (SWGLMs) were used to assess the relationship between W and CVD. Mediated analyses were used to explore lipids, cell inflammatory parameters, and MHR in the possible mediating pathways between W and CVD. In SWGLM, we found that W enhances the risk of CVD, especially congestive heart failure (CHF), coronary heart disease (CHD), and angina pectoris (AP). Women, higher age groups (≥ 55 years), and those with hypertension were vulnerable to W in the subgroup analysis. Mediation analysis showed that monocyte count (MC), white blood cell count (WBC), high-density lipoprotein cholesterol (HDL), and MHR played a mediating role between W and CVD in proportions of 8.49%, 3.70%, 5.18%, and 12.95%, respectively. In conclusion, our study shows that urinary W can increase the risk of CVD, especially for CHF, CHD, and AP. Women, older age groups, and people with hypertension seem to be more vulnerable to W. In addition, MC, WBC, HDL, and MHR mediated the association between W and CVD, especially MHR, which suggests that we should consider it as a priority intervention target in the future.

3 November 2022 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
SLSijun Li
Sijun Li
MQMengyao Qin
Mengyao Qin
SMShuang Mao
Shuang Mao
LMLingyun Mei
Lingyun Mei
Xinzhang CaiXinzhang Cai
Xinzhang Cai
JSJian Song
Jian Song
Background: Waardenburg syndrome (WS) is the most common form of syndromic deafness with phenotypic and genetic heterogeneity in the Chinese population. This study aimed to clarify the clinical characteristics and the genetic cause in eight Chinese WS families (including three familial and five sporadic cases). Further genotype–phenotype relationships were also investigated. Methods: All probands underwent screening for the known WS-related genes including PAX3, SOX10, MITF, EDNRB, EDN3, and SNAI2 using next-generation sequencing to identify disease-causing genes. Further validation using Sanger sequencing was performed. Relevant findings for the associated genotype–phenotype from previous literature were retrospectively analyzed. Result: Disease-causing variants were detected in all eight probands by molecular genetic analysis of the WS genes (SOX10(NM_006941.4): c.544_557del, c.553 C > T, c.762delA, c.336G > A; MITF(NM_000248.3): c.626 A > T; PAX3(NM_181459.4): c.838delG, c.452-2 A > G, c.214 A > G). Six mutations (SOX10:c.553 C > T, c.544_557del, c.762delA; PAX3: c.838delG, c.214 A > G; MITF:c.626 A > T) were first reported. Clinical evaluation revealed prominent phenotypic variability in these WS patients. Twelve WS1 cases and five WS2 cases were diagnosed in total. Two probands with SOX10 mutations developed progressive changes in iris color with age, returning from pale blue at birth to normal tan. Additionally, one proband had a renal malformation (horseshoe kidneys).All cases were first described as WS cases. Congenital inner ear malformations were more common, and semicircular malformations were exclusively observed in probands with SOX10 mutations. Unilateral hearing loss occurred more often in cases with PAX3 mutations. Conclusion: Our findings helped illuminate the phenotypic and genotypic spectrum of WS in Chinese populations and could contribute to better genetic counseling of WS.

30 November 2023 in Clinical and Experimental Otorhinolaryngology
Verified
Journal Article
Open access
PDF file
ACAnhai Chen
Anhai Chen
JLJie Ling
Jie Ling
XPXin Peng
Xin Peng
XLXianlin Liu
Xianlin Liu
SMShuang Mao
Shuang Mao
YFYong Feng
Yong Feng
Objectives. Branchio-oto syndrome (BOS) primarily manifests as hearing loss, preauricular pits, and branchial defects. EYA1 is the most common pathogenic gene, and splicing mutations account for a substantial proportion of cases. However, few studies have addressed the structural changes in the protein caused by splicing mutations and potential pathogenic factors, and several studies have shown that middle-ear surgery has limited effectiveness in improving hearing in these patients. BOS has also been relatively infrequently reported in the Chinese population. This study explored the genetic etiology in the family of a proband with BOS and provided clinical treatment to improve the patient’s hearing.Methods. We collected detailed clinical features and peripheral blood samples from the patients and unaffected individuals within the family. Pathogenic mutations were identified by whole-exome sequencing and cosegregation analysis and classified according to the American College of Medical Genetics and Genomics guidelines. Alternative splicing was verified through a minigene assay. The predicted three-dimensional protein structure and biochemical experiments were used to investigate the pathogenicity of the mutation. The proband underwent middle-ear surgery and was followed up at 1 month and 6 months postoperatively to monitor auditory improvement.Results. A novel heterozygous EYA1 splicing variant (c.1050+4 A>C) was identified and classified as pathogenic (PVS1(RNA), PM2, PP1). Skipping of exon 11 of the EYA1 pre-mRNA was confirmed using a minigene assay. This mutation may impair EYA1-SIX1 interactions, as shown by an immunoprecipitation assay. The EYA1-Mut protein exhibited cellular mislocalization and decreased protein expression in cytological experiments. Middle-ear surgery significantly improved hearing loss caused by bone-conduction abnormalities in the proband.Conclusion. We reported a novel splicing variant of EYA1 in a Chinese family with BOS and revealed the potential molecular pathogenic mechanism. The significant hearing improvement observed in the proband after middle-ear surgery provides a reference for auditory rehabilitation in similar patients.

13 January 2024 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SLsijun li
sijun li
CHChufeng He
Chufeng He
LMLingyun Mei
Lingyun Mei
XWXuewen Wu
Xuewen Wu
YFYong Feng
Yong Feng
JSJian Song
Jian Song